These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31169739)

  • 21. Evaluation of the effectiveness of an outreach clinical mentoring programme in support of paediatric HIV care scale-up in Botswana.
    Workneh G; Scherzer L; Kirk B; Draper HR; Anabwani G; Wanless RS; Jibril H; Gaetsewe N; Thuto B; Tolle MA
    AIDS Care; 2013; 25(1):11-9. PubMed ID: 22533352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?
    Euvrard J; Schulz T; Hilderbrand K; Bosland M; Osler M; Boulle A; Davies MA
    S Afr Med J; 2019 Feb; 109(3):174-177. PubMed ID: 30834874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A descriptive retrospective study on HIV care cascade in a tertiary hospital in the Philippines.
    Nepomuceno M; Abad CL; Salvaña EM
    PLoS One; 2023; 18(1):e0281104. PubMed ID: 36719909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care-a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999-2013.
    Zeitlmann N; Gunsenheimer-Bartmeyer B; Santos-Hövener C; Kollan C; An der Heiden M;
    BMC Infect Dis; 2016 Dec; 16(1):739. PubMed ID: 27927190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Viral Suppression among Adults Living with HIV/AIDS in Nigeria: A Retrospective Chart Review.
    Ogunyinka IA; Shaibu RO; Abubakar K; Yahaya M; Chukwudi UE; Usman ML; Abdulazeez LA
    Ann Afr Med; 2024 Apr; 23(2):125-131. PubMed ID: 39028159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after study.
    Lebelonyane R; Bachanas P; Block L; Ussery F; Abrams W; Roland M; Theu J; Kapanda M; Matambo S; Lockman S; Gaolathe T; Makhema J; Moore J; Jarvis JN
    Lancet HIV; 2020 Aug; 7(8):e545-e553. PubMed ID: 32763218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
    Farahani M; Vable A; Lebelonyane R; Seipone K; Anderson M; Avalos A; Chadborn T; Tilahun H; Roumis D; Moeti T; Musuka G; Busang L; Gaolathe T; Malefho KC; Marlink R
    Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
    Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
    PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HIV care continuum among resident and non-resident populations found in venues in East Africa cross-border areas.
    Edwards JK; Arimi P; Ssengooba F; Mulholland G; Markiewicz M; Bukusi EA; Orikiiriza JT; Virkud A; Weir S
    J Int AIDS Soc; 2019 Jan; 22(1):e25226. PubMed ID: 30675984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.
    Coffey S; Bacchetti P; Sachdev D; Bacon O; Jones D; Ospina-Norvell C; Torres S; Lynch E; Camp C; Mercer-Slomoff R; Lee S; Christopoulos K; Pilcher C; Hsu L; Jin C; Scheer S; Havlir D; Gandhi M
    AIDS; 2019 Apr; 33(5):825-832. PubMed ID: 30882490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Head and Neck Cancers With or Without Comorbid HIV Infection in Botswana.
    McGinnis GJ; Ning MS; Bvochora-Nsingo M; Chiyapo S; Balang D; Ralefala T; Lin A; Zetola NM; Grover S
    Laryngoscope; 2021 May; 131(5):E1558-E1566. PubMed ID: 33098322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP).
    Marukutira T; Block L; Alwano MG; Behel S; Jarvis JN; Chakalisa U; Powis K; Novitsky V; Bapati W; Wang H; Ussery F; Lebelonyane R; Mills LA; Moore J; Bachanas P
    PLoS One; 2019; 14(8):e0221629. PubMed ID: 31465494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respective roles of migration and social deprivation for virological non-suppression in HIV-infected adults on antiretroviral therapy in France.
    Raho-Moussa M; Guiguet M; Michaud C; Honoré P; Palacios C; Boué F; Azghay M; Kansau I; Chambrin V; Kandel T; Favier M; Miekoutima E; Sayre N; Pignon C; Shoai M; Bouchaud O; Abgrall S
    PLoS One; 2019; 14(3):e0213019. PubMed ID: 30845270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
    Gatey C; Brun A; Hamet G; Diamantis S; Sellier P; Bouchaud O; Garrait V; Rozenbaum W; Molina JM; Abgrall S;
    HIV Med; 2019 Feb; 20(2):175-181. PubMed ID: 30506853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HIV care cascade for adolescents initiated on antiretroviral therapy in a health district of South Africa: a retrospective cohort study.
    Haghighat R; Toska E; Bungane N; Cluver L
    BMC Infect Dis; 2021 Jan; 21(1):60. PubMed ID: 33435861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
    Lebelonyane R; Bachanas P; Block L; Ussery F; Alwano MG; Marukutira T; El Halabi S; Roland M; Abrams W; Ussery G; Miller JA; Lockman S; Gaolathe T; Holme MP; Hader S; Mills LA; Wirth K; Bock N; Moore J
    PLoS One; 2021; 16(8):e0255227. PubMed ID: 34375343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana.
    Steele KT; Steenhoff AP; Newcomb CW; Rantleru T; Nthobatsang R; Lesetedi G; Bellamy SL; Nachega JB; Gross R; Bisson GP
    PLoS One; 2011; 6(6):e20010. PubMed ID: 21698283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
    Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
    BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Viral Suppression Among a Cohort of Adolescents and Young Adults with Behaviorally Acquired Human Immunodeficiency Virus.
    Wood SM; Lowenthal E; Lee S; Ratcliffe SJ; Dowshen N
    AIDS Patient Care STDS; 2017 Sep; 31(9):377-383. PubMed ID: 28891717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.